Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Dermatitis|Prevention & Control|Epigallocatechin Gallate
Interventions: DRUG: EGCG|DRUG: placebo
Sponsor: Shandong Cancer Hospital and Institute